Cardiomyocyte antisense transcription regulates exon usage in the elastic spring region of Titin to modulate sarcomere function

Selvi Celik,Ludvig Hyrefelt,Tomasz Czuba,Yuan Li,Juliana Assis,Oscar Andre,Joakim Sandstedt,Pontus Nordenfelt,Kristina Vukusic,J. Gustav Smith,Olof Gidlof
DOI: https://doi.org/10.1101/2024.07.10.602998
2024-07-11
Abstract:Background: Alternative splicing of TTN I-band exons produce protein isoforms with variable size and elasticity, but the mechanisms regulating TTN exon skipping and isoform composition in the human heart are not well studied. Non-coding antisense transcripts have been shown to regulate alternative splicing of the sense gene. The TTN gene locus harbours antisense transcripts with unknown function in the human heart. The aim of this study was to determine if TTN antisense transcripts play a role in alternative splicing of TTN. Methods: RNA-sequencing and RNA in situ hybridization (ISH) of cardiac tissue from unused donor hearts (n=7) and human induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) were used to determine the expression and localization of TTN antisense transcripts. The effect of siRNA-mediated knock down of TTN antisense transcripts on TTN exon usage in iPS-CMs was determined using RNA-sequencing. Live cell imaging was used to analyze the effect of antisense transcript knock down on sarcomere properties. RNA ISH, immunofluorescence and high content microscopy was performed in iPS-CMs to study the interaction between antisense transcripts, TTN mRNA and splice factor protein RBM20. Results: In mapping TTN antisense transcription, we found that TTN-AS1-276 was the predominant transcript in the human heart and that it was mainly localized in cardiomyocyte nuclei. Knock down of TTN-AS1-276 in human iPS-CMs resulted in decreased interaction between the splicing factor RBM20 and TTN pre-mRNA, decreased TTN I-band exon skipping, and markedly lower expression of the stiff N2B isoform Furthermore, knockdown resulted in longer sarcomeres with preserved alignment, improved fractional shortening and relaxation times. Conclusions: We demonstrate a role for the cardiac TTN antisense transcript TTN-AS1-276 in facilitating alternative splicing of TTN and regulating sarcomere properties. This transcript could constitute a target for improving cardiac passive stiffness and diastolic function in conditions such as heart failure with preserved ejection fraction.
Molecular Biology
What problem does this paper attempt to address?